On February 29, 2024, BioNexus Gene Lab Corp. filed a definitive information statement and Notice of Stockholder Action by Written Consent is being furnished by the Company to its stockholders of record as of February 29, 2024, to inform its stockholders that the holders of approximately 50.1% of its outstanding voting securities as of November 2, 2023, have (i) removed the following individuals from the Board: Yeat Min Fong, Chi Yuen Leong, Yee Ming Wong, Teng Fook Fong, Chee Keong Yap, Chak Hua Yew, Boon Teong Teoh, and Chai Ping Lin and (2) nominated and elected the following individuals to the Board: Koon Wai Wong, Wei Foong Lim, and Muhammad Azrul bin Abdul Hamid for a term until the next annual meeting of shareholders and thereafter until his successor shall have been elected and qualified.